FDA Drug Recalls

Recalls / Class II

Class IID-0399-2026

Product

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

Brand name
Amnesteem
Generic name
Isotretinoin
Active ingredient
Isotretinoin
Route
Oral
NDCs
0378-6611, 0378-6612, 0378-6613, 0378-6614
FDA application
ANDA075945
Affected lot / code info
Lot #: 3116110, 3116130, Exp. Date 07/2026

Why it was recalled

Failed Dissolution Specifications

Recalling firm

Firm
MYLAN PHARMACEUTICALS INC
Manufacturer
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1311 Pineview Dr, N/A, Morgantown, West Virginia 26505-3276

Distribution

Quantity
34850 blister packs
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2026-02-24
FDA classified
2026-03-19
Posted by FDA
2026-03-11
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0399-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Amnesteem · FDA Drug Recalls